The FDA approved a blood test for early detection of Alzheimer's disease that should, for the first time, open the door to testing accessibility for more of those at risk.
The FDA approved a blood test for early detection of Alzheimer's disease that should, for the first time, open the door to testing accessibility for more of those at risk.